Transaction · 0001601830-26-000103

Borgeson Blake

Borgeson Blake, DIR, reported an open-market or private sale at RECURSION PHARMACEUTICALS, INC. involving 30000.000000 shares for an estimated $100200.00. Reported holdings after the transaction were 6158287.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SDIR
RXRXRECURSION PHARMACEUTICALS, INC.
Filing timeSep 02
Trade dateSep 01, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$3.38
Pre-filing
1mo ago -11.2%1w ago +3.8%1d ago +0.6%
Returns since
7d +0.0%30d +0.0%90d +0.0%180d +0.0%1y +0.0%

RXRX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
RXRX since 2026-09-02Filed 2 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001601830-26-000103
Class A Common Stock
Transaction date
Sep 01, 2026
Filed Sep 02, 2026, 10:01 PM · 1d delay
Shares
30.0k sh
$334 per share
Estimated value
-$10.0M
Computed from shares × price
Holdings after
6.15M sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2025.

Original filing · 0001601830-26-000103
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

RXRX